Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia

Antipsychotic treatment resistance in schizophrenia remains a major issue in psychiatry. Nearly 30% of patients with schizophrenia do not respond to antipsychotic treatment, yet the underlying neurobiological causes are unknown. All effective antipsychotic medications are thought to achieve their ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Amato, Davide, Kruyer, Anna, Samaha, Anne-Noël, Heinz, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557273/
https://www.ncbi.nlm.nih.gov/pubmed/31214054
http://dx.doi.org/10.3389/fpsyt.2019.00314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557273/
https://www.ncbi.nlm.nih.gov/pubmed/31214054
http://dx.doi.org/10.3389/fpsyt.2019.00314

Ejemplares similares